900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Adenocarcinoid tumour	Well-differentiated neuroendocrine tumor (morphologic abnormality)
Adenocarcinoma and squamous carcinoma histologic grade	Histologic grade of neoplasm (observable entity)
Adenocarcinoma, no subtype	Adenocarcinoma (morphologic abnormality)
Adenocarcinoma, no subtype, high grade	High grade adenocarcinoma (morphologic abnormality)
Adenocarcinoma, no subtype, intermediate grade	Intermediate grade adenocarcinoma (morphologic abnormality)
Adenocarcinoma, no subtype, low grade	Low grade adenocarcinoma (morphologic abnormality)
Adenofibroma, no International Classification of Diseases for Oncology subtype	Benign adenofibroma (morphologic abnormality)
Adenoma, no subtype	Adenoma (morphologic abnormality)
Adenosine 3mg/mL infusion solution 10mL vial	Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug)
Adhesiolysis - action	Dissection - action
Adipose tissue reduction operation NOS	Adipose tissue reduction operation
Adipose tissue reduction operation NOS	Adipose tissue reduction operation
Adjudicator NOS	Adjudicator
Adjudicator NOS	Adjudicator
Adjustment of external splintage	Adjusting of splint
Adjustment reaction in infancy	Adjustment reaction in infancy (disorder)
Adjustment reaction of adolescence	Adjustment reaction of adolescence (disorder)
Adjustment reaction of adult life	Adjustment reaction of adult life (disorder)
Adjustment reaction of childhood	Adjustment reaction of childhood (disorder)
Adjustment reaction of late life	Adjustment reaction of late life (disorder)
Adjustment to prosthesis in organ NOC	Prosthetic readjustment
Adjustments to denture by other than dentist providing appliances	Adjust denture
Administration	The act of putting or inserting an object AND/OR substance into or onto the body.
Administration	The act of putting or inserting an object AND/OR substance into or onto the body.
Administration	The act of putting or inserting an object AND/OR substance into or onto the body.
Administration	The act of putting or inserting an object AND/OR substance into or onto the body.
Administration of RhD immune globulin	Administration of human anti-D immunoglobulin (procedure)
Administration of RhD immune globulin declined	Administration of human anti-D immunoglobulin declined
Administration of anesthesia for obstetric procedure	Administration of anesthesia (procedure)
Administration of anesthesia for procedure	Administration of anesthesia (procedure)
Administration of contaminated substance NOS	Medical accident to patient during surgical and medical care (event)
Administration of contaminated substance NOS	Medical accident to patient during surgical and medical care (event)
Administration of other contaminated substance	Medical accident to patient during surgical and medical care (event)
Administration of prescribed medications and solutions	Administration of medication
Administration of prescribed medications based on arterial blood gas results	Administration of medication
Administration of skin test by nurse	Skin test
Administration of substance	The act of putting or inserting an object AND/OR substance into or onto the body.
Administration of substance by intravenous piggyback	Administration via intravenous route (procedure)
Administration of substance into bladder via intravesical route	Administration into urinary bladder via intravesical route
Administration of substance via enteral route	Administration via enteral route (procedure)
Administration of substance via gastroenteral route	Administration via digestive tract route that begins in the gastrointestinal tract (from the upper esophagus through the rectum).
Administration of substance via intraarterial route	Administration via intraarterial route
Administration of substance via intravenous route	Administration via intravenous route (procedure)
Administration of substance via oral route	Administration via oral route (procedure)
Administration of substance via specific route	Administration via specific route
Administration of substance via subcutaneous route	Administration via subcutaneous route
Administration of substance via topical route	Administration via topical route
Administration of substance via vaginal route	Medication administration: vaginal
Administration of syntometrine	Administration of ergometrine and oxytocin
Administration of therapeutic medication	Administration of medication
Administration of therapeutic substance	Administration of medication
Administration of therapeutic substance	Administration of medication
Administration of therapeutic substance into artery	Administration via intraarterial route
Administration of vaccine product containing only Human papillomavirus 9 antigen	Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine
Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens	Administration of pneumococcal 13-valent conjugate vaccine
Administrative and indirect care procedures	Procedure
Admission funding status NOS	Admission funding status (finding)
Admission funding status NOS	Admission funding status (finding)
Admit hospital emergency NOS	Emergency hospital admission
Admit hospital emergency NOS	Emergency hospital admission
Admit medical emergency unspecified	Emergency hospital admission
Admit medical emergency unspecified	Emergency hospital admission
Admit surgical emergency unspecified	Emergency hospital admission
Admit surgical emergency unspecified	Emergency hospital admission
Admit to intensive c.u. NOS	Admission to intensive care unit
Admit to intensive care unit NOS	Admission to intensive care unit
Adrenal cortex agent	Adrenal cortex hormone
Adrenal cortical adenoma - category	Benign adrenal cortical adenoma (morphologic abnormality)
Adrenal cortical adenoma, no International Classification of Diseases for Oncology subtype	Benign adrenal cortical adenoma (morphologic abnormality)
Adrenal hormone agent	Adrenal hormone
Adrenaline 0.5% eye drops	Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution
Adrenaline 1:1000 500micrograms/0.5mL injection	Adrenaline 1 mg/mL nasal solution
Adult Kienbock's disease of bilateral lunate	Progressive avascular necrosis of bilateral lunate bones (disorder)
Adult disease	Disease
Adult periodontitis	Chronic periodontitis
Adult rhabdomyoma	Adult cellular rhabdomyoma (morphologic abnormality)
Adult screening NOS	Adult screening
Adult screening NOS	Adult screening
Adult type granulosa cell tumor of testis	Adult type granulosa cell tumor of uncertain behavior (morphologic abnormality)
Advance care planning request by patient	Subject requested advance care planning (situation)
Advancement of flap graft	Reconstruction using local advancement flap (procedure)
Advancement of mucosa of lip NEC	Advancement of mucosa of lip
Adverse effect of oral diphosphonate	Adverse reaction caused by bisphosphonate (disorder)
Adverse effects NEC	Adverse reaction (disorder)
Adverse effects NOS	Adverse reaction (disorder)
Adverse health risk due to absence of sink in residence	Lack of functioning sink in residence (finding)
Adverse health risk due to absence of toilet in residence	Lack of functioning toilet in residence
Adverse health risk due to asbestos in residence	Asbestos in residence (finding)
Adverse health risk due to carbon monoxide in residence	Carbon monoxide in residence
Adverse health risk due to infestation of residence	Infestation of place of residence (finding)
Adverse health risk due to lack of equipment for safe food storage in residence	Inadequate equipment for safe food storage in residence
Adverse health risk due to lack of food preparation equipment in residence	Inadequate food preparation equipment in residence (finding)
Adverse health risk due to lead in residence	Lead in residence
Adverse health risk due to mold in residence	Mold growth in home (finding)
Adverse health risk due to radon in residence	Radon in residence (finding)
Adverse reaction caused by acidifying agent	All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction caused by alkalizing agents	All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction caused by carbromal derivative	Adverse reaction to carbromal
Adverse reaction caused by drug primarily acting on the smooth and skeletal muscles and respiratory system	All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction caused by intravenous diphosphonate	Adverse reaction caused by bisphosphonate (disorder)
Adverse reaction caused by liver preparations and other antianemic agents	All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).

Start Previous Page 6 of 235 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)